

According to the World Health Organization (WHO), Infertility is a disorder of the male or female reproductive system defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. Infertility may occur due to male, female or unexplained factors. Worldwide estimates suggest that one in every six people of reproductive age experience infertility in their lifetime.
Doctors may advise the Fertility Panel for Women when a female is trying to start a family or when there are known or suspected problems related to fertility, such as irregular or no periods, history of frequent miscarriages, symptoms of hormonal imbalance, history of reproductive health problems, or reproductive concerns in older females as fertility potential tends to decrease with age. Additionally, this package tries to address other health conditions such as thyroid disorders, or polycystic ovarian syndrome (PCOS) which can indeed affect fertility and make it difficult to get pregnant. To understand the cause behind infertility a series of tests are needed, therefore, the Fertility Panel for Women aims at identifying potential problems affecting fertility in females. Infertility in females may be caused by a range of abnormalities of the ovaries, uterus, fallopian tubes, and the endocrine system. E2 (Estradiol), Follicle Stimulating Hormone (FSH), Luteinising Hormone (LH), Serum Prolactin affect ovarian function, ovulation and menstrual cycles. TSH (Thyroid Stimulating Hormone) levels can indicate thyroid disorders, which can affect menstrual regularity and fertility. Testosterone levels may suggest conditions like PCOS, which can interfere with normal ovulation and fertility. DHEAS levels may indicate adrenal insufficiency, impacting ovulation and fertility. AMH (Anti-Mullerian Hormone) reflects ovarian reserve; low AMH levels can suggest diminished egg quantity and quality.
Few special preparations need to be considered before undertaking Fertility Panel for Women. However, these preparations may vary depending on the individual test included in this panel.
Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation, therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for proper understanding of the test results. Discuss your symptoms and medical history to help the doctor correlate your clinical and laboratory findings. These details along with test results guide doctors in suggesting lifestyle modifications such as diet and exercise. Additionally, they help your doctor decide whether specific treatments like intrauterine insemination or in vitro fertilization are necessary to manage your condition.
The Fertility Panel for Women measures a range of key hormones and markers that provide a comprehensive assessment of a woman's reproductive health. It evaluates levels of hormones such as Dehydroepiandrosterone Sulphate (DHEA-S), which reflects adrenal function and androgen balance; Anti-Mullerian Hormone (AMH), indicating ovarian reserve; Estradiol (E2), which is crucial for menstrual cycle regulation and uterine lining preparation; Follicle Stimulating Hormone (FSH), essential for ovarian follicle development; Luteinizing Hormone (LH), which triggers ovulation; Serum Prolactin, which influences menstrual cycles and ovulation; Thyroid Stimulating Hormone (TSH), which affects thyroid function and overall hormonal balance; and Testosterone Total, which can highlight issues like polycystic ovary syndrome (PCOS). Measuring these parameters helps identify hormonal imbalances and reproductive issues that may impact a woman's ability to conceive.
A Dehydroepiandrosterone Sulphate measures the levels of dehydroepiandrosterone sulphate (DHEAS) in the blood. DHEAS is a steroid hormone that is present in both males and females. It is primarily produced by the adrenal glands, with smaller amounts produced by ovaries in females and testicles in males.
DHEAS plays a role in developing male secondary sexual characteristics at puberty. The body can convert it into more potent androgens like testosterone and androstenedione. Also, it can be converted into the female hormone estrogen.
A Dehydroepiandrosterone Sulphate helps diagnose and differentiate certain endocrine disorders, contributing to a comprehensive understanding of hormonal balance in the body.
Know more about Dehydroepiandrosterone Sulphate
The AMH (Anti-Mullerian Hormone) test measures the levels of anti-Mullerian hormone (AMH) in the body. This hormone is produced by the testes in males and the ovaries in females. In women, the test may help check fertility and predict how the body may respond to treatments like IVF. It can also help diagnose conditions such as polycystic ovary syndrome (PCOS). In boys and men, AMH reflects Sertoli cell function; low levels in infants/children can indicate testicular dysfunction, undescended testes, or some disorders of sex development. AMH interpretation in adult men is different and must be correlated with other tests.
Know more about AMH (Anti-Mullerian Hormone)
The Fertility Panel for Women is done:
- To identify the cause of infertility in females who are facing trouble getting pregnant.
- To assess the cause of irregular menstrual cycles in females.
- In case of frequent miscarriages.
- In females with polycystic ovarian syndrome (PCOS) and thyroid problems.
- To diagnose disorders of the pituitary gland or diseases involving the ovaries in females.
- Overnight fasting is preferred but not mandatory. Follow the doctor's instructions regarding fasting requirements.
- Do not stop taking your thyroid medications on the day of the test unless otherwise advised by the doctor.
- In females, the preferred sampling time is day 2 or 3 of the menstrual cycle for LH & FSH.
- Sample to be given at the same time of the day in follow-up cases.
- For AMH- If you take hormonal birth control pills, consult your doctor as they can interfere with the results.
































